Valuation : Monogram Technologies Inc.

Market Cap 244M 210M 199M 180M 338M 23.29B 341M 2.36B 909M 11.85B 915M 895M 37.45B P/E 2023
-5.61x
P/E 2024 -4.73x
Enterprise Value 228M 197M 187M 169M 317M 21.83B 319M 2.21B 852M 11.1B 858M 839M 35.09B EV / Sales 2023
257,522,925x
EV / Sales 2024 -
Free-Float
64.74%
Yield 2023 *
-
Yield 2024 -

Last Transcript : Monogram Technologies Inc.

1 year 5.67
Extreme 5.6703
6.42
3 years 1.53
Extreme 1.53
6.42
5 years 1.53
Extreme 1.53
48.99
10 years 1.53
Extreme 1.53
48.99
Date Insider Type Main position Quantity % Market Cap. Importance
7/10/25 Issuer sale

Chief Financial Officer

411,385 1.0125%
7/10/25 Issuer sale

Chief Executive Officer

5,566,330 13.6993%
7/10/25 Issuer sale

Director

40,000 0.0984%
Change 5-day change 1-year change 3-year change Capi.($)
-1.80%-.--%+4.35%+99.34% 244M
+2.06%-9.10%-28.12%-7.32% 106B
-1.66%-5.22%-28.22%-5.26% 11.47B
-1.84%-5.76%+102.09%+119.72% 9.86B
-1.34%-6.25%-55.03%-72.15% 3.94B
-2.84%-6.11%-30.21%+24.24% 2.33B
+7.16%+15.73%-8.81%-66.55% 2.11B
+1.47%-5.12% - - 1.84B
-2.10%-4.52%-23.51%-30.79% 1.5B
Average -0.10%-2.67%-8.43%+7.65% 15.44B
Weighted average by Cap. +1.32%-7.88%-19.17%-0.32%

Financials

2023 2024
Net sales 0.36 0.31 0.3 0.27 0.51 34.87 0.51 3.54 1.36 17.74 1.37 1.34 56.06 -
Net income -13.75M -11.86M -11.23M -10.17M -19.06M -1.31B -19.21M -133M -51.23M -668M -51.6M -50.48M -2.11B -16.33M -14.09M -13.34M -12.08M -22.65M -1.56B -22.82M -158M -60.85M -793M -61.3M -59.97M -2.51B
Net Debt -13.1M -11.3M -10.7M -9.69M -18.17M -1.25B -18.31M -127M -48.81M -636M -49.17M -48.1M -2.01B -15.33M -13.22M -12.52M -11.34M -21.26M -1.46B -21.42M -148M -57.12M -745M -57.53M -56.29M -2.35B
Logo Monogram Technologies Inc.
Monogram Technologies Inc. is an artificial intelligence (AI)-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining 3D printing, advanced machine vision, AI and robotics. The Company's mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its FDA-cleared mPress press-fit implants. The Company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. It is also exploring other clinical and commercial applications for mBos with mVision navigation. Its mVision technology leverages AI-trained algorithms to track pre-identified objects in real-time.
Employees
-
  1. Stock Market
  2. Stocks
  3. MGRM Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!